Authors:
You, JHS
Lee, KKC
Ho, SSS
Sung, JJY
Kung, NNS
Yung, M
Lee, C
Yee, GC
Citation: Jhs. You et al., Economic analysis of four triple regimens for the treatment of Helicobacter pylori-related peptic ulcer disease in in-patient and out-patient settings in Hong Kong, ALIM PHARM, 15(7), 2001, pp. 1009-1015
Citation: Bcy. Wong et al., Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study, ALIM PHARM, 15(6), 2001, pp. 843-849
Citation: Jjy. Sung et al., Incidence of gastroesophageal malignancy in patients with dyspepsia in Hong Kong: implications for screening strategies, GASTROIN EN, 54(4), 2001, pp. 454-458
Citation: Sk. Ma et al., beta-thalassemia intermedia caused by compound heterozygosity for Hb Malay(beta codon 19 AAC -> AGC; Asn -> Ser) and codons 41/42 (-CTTT) beta(0)-thalassemia mutation, AM J HEMAT, 64(3), 2000, pp. 206-209
Citation: Nns. Kung et al., One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: A prospective randomized controlled trial, AM J GASTRO, 94(3), 1999, pp. 721-724